AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . February 21st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HAART Monitoring - HPLC/UV effective for therapeutic antiretroviral drug monitoring
HIV/AIDS Pathogenesis - Improved control of HIV-2 infection may relate to contribution of CD4 response
HIV/AIDS Research - Annexin II may be new target for prevention of HIV-1 infection
HIV/AIDS Therapy - Curcumin inhibits acetylation of HIV Tat by p300 as well as virus proliferation
HIV/AIDS Therapy - P-TEFb kinase inhibitor flavopiridol inhibits HIV transcription elongation
Alcohol Use - Many alcohol-dependent HIV patients need assistance adhering to medications
Antimicrobial Resistance - Bayesian model predicts risk of emerging resistance to antimicrobials
Business Update - Health products developer and marketer provides R&D update
Business Update - Nutraceutical company announces partnership with Planta Analytica
Diagnostics - Diagnostics company expands into Eastern Europe, Taiwan with HIV test kit
Drug Development - Final results of phase I/II trial of AVR118 presented
Drug Development - HIV/HTLV-1 protease inhibitors and antimalarial compounds developed
Drug Resistance - Tenofovir reduces hepatitis B virus load in HIV-positive patients
Finance - Fuzeon maker reports Q2 EPS of $0.07 ($0.13 excluding merger expenses)
Finance - RNAi-focused company agrees to $21.3 million private placement of common stock
HIV/AIDS Awarwness - Media company, Kaiser Family Foundation launch year 3 of Know HIV/AIDS campaign
HIV/AIDS Coinfection - HAART immune reconstitution trigger adverse effects in M. leprae coinfection
HIV/AIDS Epidemiology - Report: AIDS on the rise among blacks
HIV/AIDS Funding - WHO announces $2 billion gap in financing for AIDS treatment
HIV/AIDS Pathogenesis - CCR5/CCR2 genetic variants not responsible for maintenance of HIV nonprogression
HIV/AIDS Pathogenesis - Changes in HIV-1 V3 region correspond with disease progression
HIV/AIDS Pathogenesis - HIV-1 gp120 reduces brain-derived neurotrophic factor levels
HIV/AIDS Pathogenesis - Studies add new findings to HIV/AIDS pathogenesis body of knowledge
HIV/AIDS Prevention - HIV-infected gay men acknowledge risky sex behavior
HIV/AIDS Prevention - Health officials talk of eliminating AIDS in infants
HIV/AIDS Prevention - Policies and programs must look to behavior as well as biology
HIV/AIDS Research - Peptides specifically binding to HIV-1 psi RNA selected/characterized
HIV/AIDS Research - Pharma company submits three filings of antiretroviral agents to WHO
HIV/AIDS Screening - HIV screening based on patient complaint is cost-effective in low-resource areas
HIV/AIDS Therapy - FDA grants tentative approval to generic AIDS drug regimen
HIV/AIDS Therapy - Highly potent HIV entry inhibitors developed
HIV/AIDS Therapy - Inducible short hairpin RNA stems HIV replication in mammalian cells
HIV/AIDS Therapy - Needle-free administration of Fuzeon achieves equivalent levels as standard
HIV/AIDS Therapy - Patient enrollment in phase 3 trial of somatropin injection for HARS complete
HIV/AIDS Therapy - Pharmaceutical company selects lab service for HIV monotherapy trial
HIV/AIDS Therapy - Reports describe recent advances in HIV/AIDS therapy research
HIV/AIDS Vaccine - HIV-1-induced migration of dendritic cells linked to MAPK pathway activation
HIV/AIDS Vaccine - Investigational HIV/AIDS vaccine candidate advances to phase II efficacy testing
HIV/AIDS Vaccine - SHIV virus-like particles bind and activate human dendritic cells
HIV/AIDS Vaccine - Secondary HIV infections after single exposure in primates investigated
HIV/AIDS Vaccines - Recent findings in HIV/AIDS vaccines provide new insights
HIV/AIDS-Related Anemia - Altered iron metabolism model proposed to explain anemias in HIV disease
HIV/AIDS-Related Dementia - Astrocyte specific viral strains identified in HIV dementia
Hepatitis B - Drug for treatment of chronic hepatitis B up for approval
Hepatitis C - Therapeutics company expands hepatitis C collaboration with Merck
Kaposi Sarcoma-Associated Herpesvirus - 6CCC8 mutations severely reduce KSHV LANA1 binding
Kaposi Sarcoma-Associated Herpesvirus - Hematopoietic stem cell mobilization may stimulate KSHV replication
Legal Issues - Health and Human Services argues for whistleblower protection for embattled NIH
Leishmaniasis - Leishmania guyanensis cause of disseminated cutaneous leishmaniasis
Microbial Resistance - Carbapenem & ciprofloxacin most effective antimicrobials for ESBL-EK bacteremia
Patents - U.S. awards patent for peptide homologs to inhibit antigen presentation
Placental Malaria - Hemozoin regulates proinflammatory cytokines in women with placental malaria
Pneumocystis Jirovecii - P. jirovecii FAS gene cloned and DHPS drug-resistant mutation evaluated
Resveratrol - Toxicity from resveratrol seen only at the highest dose tested
Sexual & Reproductive Health - Reproductive health policy issues still exist in South Africa
Vaccine Development - HIV Tat protein breaches the skin barrier and elicits neutralizing antibodies
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
